In this webcast, not-for-profit specialists from our national office will discuss some of the AICPA's draft industry whitepapers related to the new revenue standard, and provide an update on recent changes to the OMB Uniform Guidance audit requirements.
Seismic changes in the US health industry are driving healthcare providers to rethink their business models. Primary care is a key component of success in this New Health Economy, and can even generate a return.
We bring you PwC’s perspective on deal activity in the pharmaceutical and life sciences industry. Each quarterly publication now features two sections that highlight deal activity and insights from a global view.
In this recorded webcast we discuss the latest developments in the HITRUST framework and how these changes may impact any organization operating along the healthcare continuum.
In this recorded webcast, we discuss International Tax Hot Topics.
HRI’s report lays out a vision for the US New Health Economy over the next 10 years, with likely gains and losses for the industry, and a look at implications for players old and new.
The purpose of this Alert is to highlight key changes and implications of ASU 2014-15, Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.
Pharmaceutical companies are facing new demands from consumers, regulators, insurers and independent groups.
In this recorded webcast, our tax professionals discuss key topics related to the New Markets Tax Credit program, including program structure, business eligibility, status of allocation and successful projects.
This study captures the trends of 160 companies identified as early-adopters of the new FASB issued Accounting Standards Update (ASU) 2016-09, Improvements to Employee Share-Based Payment Accounting (the Amendments).